PP
GSK icon

Pingora Partners’s GSK GSK Stock Holding History

Pingora Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$4.9K – 194
2025
Q4 		$4.9K Sell
100
-100
-50% -$4.66K ﹤0.01% 194
2025
Q3 		$8.63K Hold
200
– – 0.01% 184
2025
Q2 		$7.68K Hold
200
– – 0.01% 189
2025
Q1 		$7.75K Sell
200
-300
-60% -$11K 0.01% 190
2024
Q4 		$16.9K Hold
500
– – 0.01% 180
2024
Q3 		$20.4K Buy
+500
New +$20.5K 0.01% 173

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Pingora Partners's GSK Position: Q1 2026 in Review

Pingora Partners sold out of GSK (GSK) in Q1 2026, closing a stake of 100 shares — an estimated $4.9K sold.

Pingora Partners first reported a position in GSK in Q3 2024 and held it in 6 quarters. The position peaked at $20.4K in Q3 2024. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Pingora Partners reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
  • Pingora Partners sold 100 GSK shares in Q1 2026, an estimated $4.9K.
  • Pingora Partners first reported a position in GSK in Q3 2024 and held it in 6 quarters.
  • Pingora Partners's GSK position peaked at $20.4K in Q3 2024.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Pingora Partners's 13F filing for Q1 2026, filed 15 May 2026.